Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervix

Cancer Chemotherapy and Pharmacology

Volumn 71, Issue 3, 2013, Pages 657-662

  Shoji, Tadahiro ^a   Takatori, Eriko ^a   Saito, Tatsunori ^a   Omi, Hideo ^a   Kagabu, Masahiro ^a   Miura, Fumiharu ^a   Takeuchi, Satoshi ^a   Sugiyama, Toru ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Carboplatin; Cervical cancer; Docetaxel; Neoadjuvant chemotherapy; Non squamous cell carcinoma; Paclitaxel

Indexed keywords

ANTIEMETIC AGENT; CARBOPLATIN; DOCETAXEL; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX; TAXOID;

ADULT; ADVANCED CANCER; ANEMIA; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG POTENCY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LEUKOPENIA; NAUSEA; NEUROTOXICITY; NEUTROPENIA; NEUTROPHIL COUNT; NON SQUAMOUS CELL CERVICAL CARCINOMA; OVERALL SURVIVAL; PILOT STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADICAL HYSTERECTOMY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA; VOMITING; ADJUVANT THERAPY; CHEMICALLY INDUCED DISORDER; DISEASE FREE SURVIVAL; DOSE RESPONSE; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; SURVIVAL; UTERINE CERVIX TUMOR;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEUTROPENIA; ORGANOPLATINUM COMPOUNDS; PILOT PROJECTS; POSTOPERATIVE CARE; SURVIVAL ANALYSIS; TAXOIDS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

MLCS; MLOWN;

EID: 84875837190     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-012-2052-2     Document Type: Article

References (18)

1. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, Clarke-Pearson DL, Liao SY (1999) Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17:1339-1348 (Pubitemid 29220838)
2. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137-1143 (Pubitemid 29177872)
3. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144-1153 (Pubitemid 29177873)
4. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL III, Walker JL, Gersell D (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage 1B cervical carcinoma. N Engl J Med 340:1154-1161 (Pubitemid 29177874)
5. Peters WA III, Liu PY, Barrett RJ II, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr, Alberts DS (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606-1613 (Pubitemid 30220538)
6. Thomas GM (1999) Improved treatment for cervical cancer - concurrent chemotherapy and radiotherapy. N Engl J Med 340:1198-1200 (Pubitemid 29177880)
7. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Williams CJ (2001) Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358:781-786 (Pubitemid 32868726)
8. Sugiyama T, Nishida T, Kumagai S, Nishino S, Fujivoshi K, Okura N, Yakushiji M, Hiura M, Umesaki N (1999) Combination chemotherapy with irinotecan and cisplatin as neoadjuvant in locally advanced cervical cancer. Br J Cancer 81:95-98 (Pubitemid 29415497)
9. Shoji T, Takatori E, Hatayama S, Omi H, Kagabu M, Honda T, Kumagai S, Morohara Y, Miura F, Yoshizaki A, Sugiyama T (2010) Phase II study of tri-weekly cisplatin and irinotecan as neoadjuvant chemotherapy for locally advanced cervical cancer. Oncol lett 1:515-519
10. Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, Amunni G, Raspagliesi F, Zola P, Mangioni C, Landoni F (2002) Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 20:179-188 (Pubitemid 34032610)
11. Aoki Y, Sato T, Watanabe M, Sasaki M, Tsuneki I, Tanaka K (2001) Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusion of cisplatin combined with 5FU for locally advanced cervical adenocarcinoma. Gynecol Oncol 83:496-499 (Pubitemid 32494669)
12. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, Favini G, Ferri L, Mangioni C (1997) Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350:535-540 (Pubitemid 27348428)
13. Thigpen JT, Blessing JA, Fowler WC Jr, Hatch K (1986) Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Cancer Treat Rep 70:1097-1100 (Pubitemid 16023725)
14. Sutton GP, Blessing JA, DiSaia PJ, McGuire WP (1993) Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 49:48-50 (Pubitemid 23148581)
15. Look KY, Blessing JA, Valea FA, McGehee R, Manetta A, Webster KD, Andersen WA (1997) Phase II trial of 5-fluorouracil and high-dose leucovorin in recurrent adenocarcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 67:255-258 (Pubitemid 28034631)
16. Rose PG, Blessing JA, Buller RE, Mannel RS, Webster KD (2003) Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 89:267-270 (Pubitemid 36457875)
17. Curtin JP, Blessing JA, Webster KD, Rose PG, Mayer AR, Fowler WC Jr, Malfetano JH, Alvarez RD (2001) Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol 19:1275-1278 (Pubitemid 32202530)
18. Nagao S, Fujiwara K, Oda T, Ishikawa H, Koike H, Tanaka H, Kohno I (2005) Combination chemotherapy of docetaxel and carboplatin in advanced or recurrent cervix cancer. A pilot study. Gynecol Oncol 96:805-809 (Pubitemid 40255505)